歐 穎謙

Medicine & Life Sciences

1. Botulinum Toxins 75%
2. Urinary Bladder 69%
3. Underactive Urinary Bladder 64%
4. Urinary Tract 63%
5. Injections 46%
6. Spinal Cord Injuries 40%
7. Urodynamics 38%
8. Prostate 35%
9. Ureteral Neoplasms 34%
10. Urinary Bladder Neck Obstruction 32%
11. Carcinoma 30%
12. Urinary Incontinence 29%
13. Therapeutics 25%
14. Therapeutic Uses 24%
15. Laser Therapy 22%
16. Overactive Urinary Bladder 20%
17. Renal Cell Carcinoma 20%
18. Cell- and Tissue-Based Therapy 20%
19. Urinary Catheterization 17%
20. Lower Urinary Tract Symptoms 17%
21. Monocytes 17%
22. Neoplasms 17%
23. Necrosis 16%
24. Urine 16%
25. Stem Cells 15%
26. Lymphocytes 14%
27. Quality of Life 14%
28. Volatilization 14%
29. Elderly 14%
30. Randomized Controlled Trials 14%
31. Exercise 13%
32. Cell Line 12%
33. Population 12%
34. Erlotinib Hydrochloride 10%
35. Urinary Retention 10%
36. Control Groups 8%
37. MAP Kinase Signaling System 8%
38. Diaries 8%
39. Exosomes 8%
40. ErbB Receptors 8%
41. Kidney 7%
42. In Vitro Techniques 7%
43. Referral and Consultation 7%
44. Safety 6%